Agenda
Day 1, Tuesday, November 1, 2022 (8:00–11:45 a.m. ET)
8:00–8:40 |
Opening Remarks and Acknowledgements Welcoming Remarks from the National Cancer Institute Dr. Katrina Goddard, Director, Division of Cancer Control and Population Sciences, National Cancer Institute, NIH Dr. Stephen Chanock, Director, Division of Cancer Epidemiology & Genetics, National Cancer Institute, NIH Dr. Emily Tonorezos, Director, Office of Cancer Survivorship, Division of Cancer Control and Population Sciences, National Cancer Institute, NIH |
8:40–9:45 |
SESSION I: DATA SHARING |
|
Moderators: |
8:40–9:05 |
NIH Data Sharing Policy Update Q & A Session |
9:05–9:25 |
Advances in Data Science from the NIH perspective Q & A Session |
9:25–9:45 |
Virtual Pooled Registry Cancer Linkage System: Current and Future Initiatives Q & A Session |
9:45–10:00 |
Break |
10:00–11:30 |
SESSION II: CHALLENGES AND OPPORTUNITIES FOR COHORTS OF CANCER SURVIVORS |
|
Moderators: |
10:00–11:00 |
Cohort Overview Lymphoma Epidemiology of Outcomes (LEO) Cohort England & Wales Hodgkin Lymphoma Cohort ColoCare Consortium (ColoCare) Pathways Study Susan G. Komen Tissue Bank Updates from the Director |
11:00–11:30 | Panel Discussion |
11:30–11:45 |
Associate Member Council Update Dr. Lauren E. McCullough, Emory University |
11:45 | Adjourn |
12:00–12:45 |
Networking Session Hosted by Early Career Scientists (optional) |
Day 2, Wednesday, November 2, 2022 (1:00–5:00 p.m. ET)
12:00–12:45 | General Networking Session (optional) |
1:00–1:05 |
Opening Remarks |
1:05–1:45 |
Plenary Session - State of the Science in Survivorship Research |
1:45–2:00 | Q & A Session |
2:00–3:15 |
SESSION III: DATA COLLECTION, ACCESS, AND LINKAGES |
|
Moderators: |
2:00–2:20 |
Perspectives on CMS linkage for Cancer Research in Cohort Studies |
2:20–2:35 | Q & A Session |
2:35–3:05 |
The All of Us Research Program- Data Types, Data Access, Data Analysis |
3:05–3:15 | Q & A Session |
3:15–3:35 |
Research Facilitation Report Dr. Roger Milne, Cancer Council Victoria |
3:35–3:50 | Break |
3:50–4:50 |
SESSION IV: COHORT CONSORTIUM PROJECT GROUP REPORT BACKS |
|
Moderators: Sexual and Gender Minority Interest Group The Breast Cancer Risk Prediction Project Prostate Cancer Cohort Consortium (PC3): A collaborative approach to an enigmatic cancer Lung Cancer Cohort Consortium (LC3) Linkage of NCI Cohort Consortium Projects Investigating the role of immune markers in driving sex-specific differences in Glioblastoma (GBM) development |
4:50 | Closing Remarks and Adjourn Dr. Heather Eliassen, Harvard Medical School and Harvard School of Public Health |